US FDA Data Strategy Will Cover Security For Internal Sharing
FDA seeks expert comments during an upcoming public meeting on strategies to facilitate various centers combining and sharing data.
You may also be interested in...
US FDA’s Data Strategy Under Increasing Pressure From Coronavirus Pandemic
As agency prepares to hear from stakeholders on its strategy, real-world data precedents already are being set thanks to COVID-19, Aetion tells the Pink Sheet.
US FDA Tech Modernization Plan’s Costs Uncertain
Agency officials determining needs using existing budgets before requesting more funds and will engage with tech investors for design advice.
US FDA’s Human Drugs Program Suffers In Adjustment Of Agency Priorities
President Trump's budget request would boost compounding and vaccines by $5m, but human drugs program would lose $4.8m in training funds.